Display options
Cite
Thi AM, Shewade HD, Kyaw NT, et al. Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar. Public Health Action. 2016;6(2):111-7doi: 10.5588/pha.16.0009.
Thi, A. M., Shewade, H. D., Kyaw, N. T., Oo, M. M., Aung, T. K., Aung, S. T., Oo, H. N., Win, T., & Harries, A. D. (2016). Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar. Public health action, 6(2), 111-7. https://doi.org/10.5588/pha.16.0009
Thi, A M, et al. "Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar." Public health action vol. 6,2 (2016): 111-7. doi: https://doi.org/10.5588/pha.16.0009
Thi AM, Shewade HD, Kyaw NT, Oo MM, Aung TK, Aung ST, Oo HN, Win T, Harries AD. Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar. Public Health Action. 2016 Jun 21;6(2):111-7. doi: 10.5588/pha.16.0009. PMID: 27358804; PMCID: PMC4913673.
Copy Download .nbib Format: NLM
Share it on

Public Health Action. 2016 Jun 21;6(2):111-7. doi: 10.5588/pha.16.0009.

Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar.

Public health action

A M Thi, H D Shewade, N T T Kyaw, M M Oo, T K Aung, S T Aung, H N Oo, T Win, A D Harries

Affiliations

  1. International Union Against Tuberculosis and Lung Disease (The Union), Mandalay, Myanmar.
  2. The Union, South-East Asia Office, New Delhi, India.
  3. National Tuberculosis Programme, Ministry of Health, Nay Pyi Taw, Myanmar.
  4. National AIDS Programme (NAP), Ministry of Health, Nay Pyi Taw, Myanmar.
  5. NAP, Ministry of Health, Mandalay, Myanmar.
  6. The Union, Paris, France ; London School of Hygiene & Tropical Medicine, London, UK.

PMID: 27358804 PMCID: PMC4913673 DOI: 10.5588/pha.16.0009

Abstract

SETTING: Integrated HIV Care programme, Mandalay, Myanmar.

OBJECTIVES: To determine time to starting antiretroviral treatment (ART) in relation to anti-tuberculosis treatment (ATT) and its association with TB treatment outcomes in patients co-infected with tuberculosis (TB) and the human immunodeficiency virus (HIV) enrolled from 2011 to 2014.

DESIGN: Retrospective cohort study.

RESULTS: Of 1708 TB-HIV patients, 1565 (92%) started ATT first and 143 (8%) started ART first. Treatment outcomes were missing for 226 patients and were thus not included. In those starting ATT first, the median time to starting ART was 8.6 weeks. ART was initiated after 8 weeks in 830 (53%) patients. Unsuccessful outcome was found in 7%, with anaemia being an independent predictor. In patients starting ART first, the median time to starting ATT was 21.6 weeks. ATT was initiated within 3 months in 56 (39%) patients. Unsuccessful outcome was found in 12%, and in 20% of those starting ATT within 3 months. Patients with CD4 count <100/mm(3) had a four times higher risk of an unsuccessful outcome.

CONCLUSIONS: Timing of ART in relation to ATT was not an independent risk factor for unsuccessful outcome. Extensive screening for TB with rapid and sensitive diagnostic tests in HIV-infected persons and close monitoring of anaemia and immunosuppression are recommended to further improve TB treatment outcomes among patients with TB-HIV.

Keywords: HIV-associated TB; SORT IT; adverse TB treatment outcomes; early ART initiation; operational research; treatment outcome

References

  1. BMC Med. 2013 Oct 29;11:231 - PubMed
  2. BMC Infect Dis. 2014 Jun 04;14:304 - PubMed
  3. N Engl J Med. 2015 Aug 27;373(9):795-807 - PubMed
  4. N Engl J Med. 2011 Oct 20;365(16):1492-501 - PubMed
  5. N Engl J Med. 2015 Aug 27;373(9):808-22 - PubMed
  6. J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):229-34 - PubMed
  7. J Acquir Immune Defic Syndr. 2014 May 1;66(1):33-40 - PubMed
  8. PLoS One. 2014 Nov 12;9(11):e112017 - PubMed
  9. Int J Tuberc Lung Dis. 2012 May;16(5):618-24 - PubMed
  10. Clin Infect Dis. 2009 Mar 15;48(6):829-31 - PubMed
  11. PLoS One. 2014 Sep 30;9(9):e108615 - PubMed
  12. AIDS. 2013 Oct 23;27(16):2577-86 - PubMed
  13. J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):576-84 - PubMed
  14. Lancet. 2007 Oct 20;370(9596):1453-7 - PubMed
  15. Lancet. 2004 Jan 10;363(9403):157-63 - PubMed
  16. Curr Opin Infect Dis. 2013 Feb;26(1):35-42 - PubMed
  17. Lancet. 2014 Aug 23;384(9944):682-90 - PubMed
  18. AIDS. 2008 Oct 1;22(15):1897-908 - PubMed
  19. BMC Infect Dis. 2014 Dec 21;14:3860 - PubMed
  20. N Engl J Med. 2011 Oct 20;365(16):1471-81 - PubMed
  21. HIV Med. 2014 Feb;15(2):77-85 - PubMed
  22. PLoS One. 2014 Mar 18;9(3):e91229 - PubMed
  23. N Engl J Med. 2011 Oct 20;365(16):1482-91 - PubMed

Publication Types